Warfarin Use Is Associated with Increased Mortality at One Year in Patients with Idiopathic Pulmonary Fibrosis
Rationale. Previous data suggest that warfarin may worsen outcomes in IPF in patients with no indication for anticoagulation when compared to placebo. However, warfarin continues to be widely used for cardiac and thromboembolic indications in this patient population due to unavailability of data com...
Saved in:
Main Authors: | Syeda Fatima Naqvi, Amir Humza Sohail, Dhairya A. Lakhani, James Maurer, Sarah Sofka, Yousaf B. Hadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Pulmonary Medicine |
Online Access: | http://dx.doi.org/10.1155/2021/3432362 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Lee Fidler, et al.
Published: (2015-01-01) -
Molecular genetics of idiopathic pulmonary fibrosis
by: R. N. Mustafin
Published: (2022-06-01) -
Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
by: E. Bargagli, et al.
Published: (2011-01-01) -
Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
by: Argyris Tzouvelekis, et al.
Published: (2011-01-01) -
Machine learning potential predictor of idiopathic pulmonary fibrosis
by: Chenchun Ding, et al.
Published: (2025-01-01)